Need help finding what you are looking for?
Contact Us
PUBLISHER: QYResearch | PRODUCT CODE: 1862238
PUBLISHER: QYResearch | PRODUCT CODE: 1862238
NK Cell Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
PUBLISHED:
PAGES: 116 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global market for NK Cell Therapy was estimated to be worth US$ 484 million in 2024 and is forecast to a readjusted size of US$ 1568 million by 2031 with a CAGR of 18.2% during the forecast period 2025-2031.
Natural Killer (NK) cell therapy is an immunotherapy that utilizes NK cells, a type of cytotoxic lymphocyte, to target and destroy cancer cells or virus-infected cells. Unlike T cells, NK cells can recognize and eliminate abnormal cells without prior sensitization, making them a valuable tool for innate immune response-based treatments. NK cells can be derived from peripheral blood, umbilical cord blood, induced pluripotent stem cells, or established NK cell lines, and are often modified or expanded ex vivo before being infused into patients. This therapy is primarily being developed for oncology, with applications in hematologic malignancies and solid tumors, as well as in infectious diseases.
The NK cell therapy market is rapidly emerging as a promising segment within the broader cell therapy landscape. It is gaining momentum due to its potential to overcome some of the limitations associated with other immunotherapies, such as CAR-T therapy, including lower risks of cytokine release syndrome and graft-versus-host disease. NK cell therapies are under extensive clinical investigation worldwide, with numerous preclinical and clinical trials targeting leukemia, lymphoma, and solid tumors. Companies and research institutions are actively exploring genetic modifications, such as CAR-NK cells, to enhance efficacy and specificity. Favorable regulatory trends in regions like the U.S., Europe, and Asia are contributing to faster development pathways and commercialization opportunities. Additionally, collaborations between biotech firms, pharmaceutical companies, and academic centers are accelerating innovation and expanding the therapeutic pipeline. Despite challenges in manufacturing scalability and persistence of NK cells in vivo, the market outlook remains positive. Investors are showing strong interest, and the next decade is expected to witness significant progress in both technical development and clinical adoption of NK cell therapies.
This report aims to provide a comprehensive presentation of the global market for NK Cell Therapy, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of NK Cell Therapy by region & country, by Type, and by Application.
The NK Cell Therapy market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NK Cell Therapy.
Market Segmentation
By Company
- Nektar Therapeutics
- ImmunityBio, Inc
- GC Cell
- Affimed
- Innate Pharma SA
- Fate Therapeutics
- Glycostem Therapeutics
- Dragonfly Therapeutics
- Nkarta Therapeutics
- Fortress Biotech
- Nkure
Segment by Type
- NK Cell Therapy
- CAR-NK Cell Therapy
Segment by Application
- Cancer
- Infectious Diseases
- Gastrointestinal Diseases
- Beauty and Anti-Aging
- Others
By Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of NK Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of NK Cell Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of NK Cell Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
- 1.1 NK Cell Therapy Product Introduction
- 1.2 Global NK Cell Therapy Market Size Forecast (2020-2031)
- 1.3 NK Cell Therapy Market Trends & Drivers
- 1.3.1 NK Cell Therapy Industry Trends
- 1.3.2 NK Cell Therapy Market Drivers & Opportunity
- 1.3.3 NK Cell Therapy Market Challenges
- 1.3.4 NK Cell Therapy Market Restraints
- 1.4 Assumptions and Limitations
- 1.5 Study Objectives
- 1.6 Years Considered
2 Competitive Analysis by Company
- 2.1 Global NK Cell Therapy Players Revenue Ranking (2024)
- 2.2 Global NK Cell Therapy Revenue by Company (2020-2025)
- 2.3 Key Companies NK Cell Therapy Manufacturing Base Distribution and Headquarters
- 2.4 Key Companies NK Cell Therapy Product Offered
- 2.5 Key Companies Time to Begin Mass Production of NK Cell Therapy
- 2.6 NK Cell Therapy Market Competitive Analysis
- 2.6.1 NK Cell Therapy Market Concentration Rate (2020-2025)
- 2.6.2 Global 5 and 10 Largest Companies by NK Cell Therapy Revenue in 2024
- 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NK Cell Therapy as of 2024)
- 2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
- 3.1 Introduction by Type
- 3.1.1 NK Cell Therapy
- 3.1.2 CAR-NK Cell Therapy
- 3.2 Global NK Cell Therapy Sales Value by Type
- 3.2.1 Global NK Cell Therapy Sales Value by Type (2020 VS 2024 VS 2031)
- 3.2.2 Global NK Cell Therapy Sales Value, by Type (2020-2031)
- 3.2.3 Global NK Cell Therapy Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
- 4.1 Introduction by Application
- 4.1.1 Cancer
- 4.1.2 Infectious Diseases
- 4.1.3 Gastrointestinal Diseases
- 4.1.4 Beauty and Anti-Aging
- 4.1.5 Others
- 4.2 Global NK Cell Therapy Sales Value by Application
- 4.2.1 Global NK Cell Therapy Sales Value by Application (2020 VS 2024 VS 2031)
- 4.2.2 Global NK Cell Therapy Sales Value, by Application (2020-2031)
- 4.2.3 Global NK Cell Therapy Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
- 5.1 Global NK Cell Therapy Sales Value by Region
- 5.1.1 Global NK Cell Therapy Sales Value by Region: 2020 VS 2024 VS 2031
- 5.1.2 Global NK Cell Therapy Sales Value by Region (2020-2025)
- 5.1.3 Global NK Cell Therapy Sales Value by Region (2026-2031)
- 5.1.4 Global NK Cell Therapy Sales Value by Region (%), (2020-2031)
- 5.2 North America
- 5.2.1 North America NK Cell Therapy Sales Value, 2020-2031
- 5.2.2 North America NK Cell Therapy Sales Value by Country (%), 2024 VS 2031
- 5.3 Europe
- 5.3.1 Europe NK Cell Therapy Sales Value, 2020-2031
- 5.3.2 Europe NK Cell Therapy Sales Value by Country (%), 2024 VS 2031
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific NK Cell Therapy Sales Value, 2020-2031
- 5.4.2 Asia Pacific NK Cell Therapy Sales Value by Region (%), 2024 VS 2031
- 5.5 South America
- 5.5.1 South America NK Cell Therapy Sales Value, 2020-2031
- 5.5.2 South America NK Cell Therapy Sales Value by Country (%), 2024 VS 2031
- 5.6 Middle East & Africa
- 5.6.1 Middle East & Africa NK Cell Therapy Sales Value, 2020-2031
- 5.6.2 Middle East & Africa NK Cell Therapy Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
- 6.1 Key Countries/Regions NK Cell Therapy Sales Value Growth Trends, 2020 VS 2024 VS 2031
- 6.2 Key Countries/Regions NK Cell Therapy Sales Value, 2020-2031
- 6.3 United States
- 6.3.1 United States NK Cell Therapy Sales Value, 2020-2031
- 6.3.2 United States NK Cell Therapy Sales Value by Type (%), 2024 VS 2031
- 6.3.3 United States NK Cell Therapy Sales Value by Application, 2024 VS 2031
- 6.4 Europe
- 6.4.1 Europe NK Cell Therapy Sales Value, 2020-2031
- 6.4.2 Europe NK Cell Therapy Sales Value by Type (%), 2024 VS 2031
- 6.4.3 Europe NK Cell Therapy Sales Value by Application, 2024 VS 2031
- 6.5 China
- 6.5.1 China NK Cell Therapy Sales Value, 2020-2031
- 6.5.2 China NK Cell Therapy Sales Value by Type (%), 2024 VS 2031
- 6.5.3 China NK Cell Therapy Sales Value by Application, 2024 VS 2031
- 6.6 Japan
- 6.6.1 Japan NK Cell Therapy Sales Value, 2020-2031
- 6.6.2 Japan NK Cell Therapy Sales Value by Type (%), 2024 VS 2031
- 6.6.3 Japan NK Cell Therapy Sales Value by Application, 2024 VS 2031
- 6.7 South Korea
- 6.7.1 South Korea NK Cell Therapy Sales Value, 2020-2031
- 6.7.2 South Korea NK Cell Therapy Sales Value by Type (%), 2024 VS 2031
- 6.7.3 South Korea NK Cell Therapy Sales Value by Application, 2024 VS 2031
- 6.8 Southeast Asia
- 6.8.1 Southeast Asia NK Cell Therapy Sales Value, 2020-2031
- 6.8.2 Southeast Asia NK Cell Therapy Sales Value by Type (%), 2024 VS 2031
- 6.8.3 Southeast Asia NK Cell Therapy Sales Value by Application, 2024 VS 2031
- 6.9 India
- 6.9.1 India NK Cell Therapy Sales Value, 2020-2031
- 6.9.2 India NK Cell Therapy Sales Value by Type (%), 2024 VS 2031
- 6.9.3 India NK Cell Therapy Sales Value by Application, 2024 VS 2031
7 Company Profiles
- 7.1 Nektar Therapeutics
- 7.1.1 Nektar Therapeutics Profile
- 7.1.2 Nektar Therapeutics Main Business
- 7.1.3 Nektar Therapeutics NK Cell Therapy Products, Services and Solutions
- 7.1.4 Nektar Therapeutics NK Cell Therapy Revenue (US$ Million) & (2020-2025)
- 7.1.5 Nektar Therapeutics Recent Developments
- 7.2 ImmunityBio, Inc
- 7.2.1 ImmunityBio, Inc Profile
- 7.2.2 ImmunityBio, Inc Main Business
- 7.2.3 ImmunityBio, Inc NK Cell Therapy Products, Services and Solutions
- 7.2.4 ImmunityBio, Inc NK Cell Therapy Revenue (US$ Million) & (2020-2025)
- 7.2.5 ImmunityBio, Inc Recent Developments
- 7.3 GC Cell
- 7.3.1 GC Cell Profile
- 7.3.2 GC Cell Main Business
- 7.3.3 GC Cell NK Cell Therapy Products, Services and Solutions
- 7.3.4 GC Cell NK Cell Therapy Revenue (US$ Million) & (2020-2025)
- 7.3.5 GC Cell Recent Developments
- 7.4 Affimed
- 7.4.1 Affimed Profile
- 7.4.2 Affimed Main Business
- 7.4.3 Affimed NK Cell Therapy Products, Services and Solutions
- 7.4.4 Affimed NK Cell Therapy Revenue (US$ Million) & (2020-2025)
- 7.4.5 Affimed Recent Developments
- 7.5 Innate Pharma SA
- 7.5.1 Innate Pharma SA Profile
- 7.5.2 Innate Pharma SA Main Business
- 7.5.3 Innate Pharma SA NK Cell Therapy Products, Services and Solutions
- 7.5.4 Innate Pharma SA NK Cell Therapy Revenue (US$ Million) & (2020-2025)
- 7.5.5 Innate Pharma SA Recent Developments
- 7.6 Fate Therapeutics
- 7.6.1 Fate Therapeutics Profile
- 7.6.2 Fate Therapeutics Main Business
- 7.6.3 Fate Therapeutics NK Cell Therapy Products, Services and Solutions
- 7.6.4 Fate Therapeutics NK Cell Therapy Revenue (US$ Million) & (2020-2025)
- 7.6.5 Fate Therapeutics Recent Developments
- 7.7 Glycostem Therapeutics
- 7.7.1 Glycostem Therapeutics Profile
- 7.7.2 Glycostem Therapeutics Main Business
- 7.7.3 Glycostem Therapeutics NK Cell Therapy Products, Services and Solutions
- 7.7.4 Glycostem Therapeutics NK Cell Therapy Revenue (US$ Million) & (2020-2025)
- 7.7.5 Glycostem Therapeutics Recent Developments
- 7.8 Dragonfly Therapeutics
- 7.8.1 Dragonfly Therapeutics Profile
- 7.8.2 Dragonfly Therapeutics Main Business
- 7.8.3 Dragonfly Therapeutics NK Cell Therapy Products, Services and Solutions
- 7.8.4 Dragonfly Therapeutics NK Cell Therapy Revenue (US$ Million) & (2020-2025)
- 7.8.5 Dragonfly Therapeutics Recent Developments
- 7.9 Nkarta Therapeutics
- 7.9.1 Nkarta Therapeutics Profile
- 7.9.2 Nkarta Therapeutics Main Business
- 7.9.3 Nkarta Therapeutics NK Cell Therapy Products, Services and Solutions
- 7.9.4 Nkarta Therapeutics NK Cell Therapy Revenue (US$ Million) & (2020-2025)
- 7.9.5 Nkarta Therapeutics Recent Developments
- 7.10 Fortress Biotech
- 7.10.1 Fortress Biotech Profile
- 7.10.2 Fortress Biotech Main Business
- 7.10.3 Fortress Biotech NK Cell Therapy Products, Services and Solutions
- 7.10.4 Fortress Biotech NK Cell Therapy Revenue (US$ Million) & (2020-2025)
- 7.10.5 Fortress Biotech Recent Developments
- 7.11 Nkure
- 7.11.1 Nkure Profile
- 7.11.2 Nkure Main Business
- 7.11.3 Nkure NK Cell Therapy Products, Services and Solutions
- 7.11.4 Nkure NK Cell Therapy Revenue (US$ Million) & (2020-2025)
- 7.11.5 Nkure Recent Developments
8 Industry Chain Analysis
- 8.1 NK Cell Therapy Industrial Chain
- 8.2 NK Cell Therapy Upstream Analysis
- 8.2.1 Key Raw Materials
- 8.2.2 Raw Materials Key Suppliers
- 8.2.3 Manufacturing Cost Structure
- 8.3 Midstream Analysis
- 8.4 Downstream Analysis (Customers Analysis)
- 8.5 Sales Model and Sales Channels
- 8.5.1 NK Cell Therapy Sales Model
- 8.5.2 Sales Channel
- 8.5.3 NK Cell Therapy Distributors
9 Research Findings and Conclusion
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
- 10.1.1.1 Research Programs/Design
- 10.1.1.2 Market Size Estimation
- 10.1.1.3 Market Breakdown and Data Triangulation
- 10.1.2 Data Source
- 10.1.2.1 Secondary Sources
- 10.1.2.2 Primary Sources
- 10.1.1 Methodology/Research Approach
- 10.2 Author Details
- 10.3 Disclaimer
List of Tables
- Table 1. NK Cell Therapy Market Trends
- Table 2. NK Cell Therapy Market Drivers & Opportunity
- Table 3. NK Cell Therapy Market Challenges
- Table 4. NK Cell Therapy Market Restraints
- Table 5. Global NK Cell Therapy Revenue by Company (2020-2025) & (US$ Million)
- Table 6. Global NK Cell Therapy Revenue Market Share by Company (2020-2025)
- Table 7. Key Companies NK Cell Therapy Manufacturing Base Distribution and Headquarters
- Table 8. Key Companies NK Cell Therapy Product Type
- Table 9. Key Companies Time to Begin Mass Production of NK Cell Therapy
- Table 10. Global NK Cell Therapy Companies Market Concentration Ratio (CR5 and HHI)
- Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NK Cell Therapy as of 2024)
- Table 12. Mergers & Acquisitions, Expansion Plans
- Table 13. Global NK Cell Therapy Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
- Table 14. Global NK Cell Therapy Sales Value by Type (2020-2025) & (US$ Million)
- Table 15. Global NK Cell Therapy Sales Value by Type (2026-2031) & (US$ Million)
- Table 16. Global NK Cell Therapy Sales Market Share in Value by Type (2020-2025)
- Table 17. Global NK Cell Therapy Sales Market Share in Value by Type (2026-2031)
- Table 18. Global NK Cell Therapy Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
- Table 19. Global NK Cell Therapy Sales Value by Application (2020-2025) & (US$ Million)
- Table 20. Global NK Cell Therapy Sales Value by Application (2026-2031) & (US$ Million)
- Table 21. Global NK Cell Therapy Sales Market Share in Value by Application (2020-2025)
- Table 22. Global NK Cell Therapy Sales Market Share in Value by Application (2026-2031)
- Table 23. Global NK Cell Therapy Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
- Table 24. Global NK Cell Therapy Sales Value by Region (2020-2025) & (US$ Million)
- Table 25. Global NK Cell Therapy Sales Value by Region (2026-2031) & (US$ Million)
- Table 26. Global NK Cell Therapy Sales Value by Region (2020-2025) & (%)
- Table 27. Global NK Cell Therapy Sales Value by Region (2026-2031) & (%)
- Table 28. Key Countries/Regions NK Cell Therapy Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
- Table 29. Key Countries/Regions NK Cell Therapy Sales Value, (2020-2025) & (US$ Million)
- Table 30. Key Countries/Regions NK Cell Therapy Sales Value, (2026-2031) & (US$ Million)
- Table 31. Nektar Therapeutics Basic Information List
- Table 32. Nektar Therapeutics Description and Business Overview
- Table 33. Nektar Therapeutics NK Cell Therapy Products, Services and Solutions
- Table 34. Revenue (US$ Million) in NK Cell Therapy Business of Nektar Therapeutics (2020-2025)
- Table 35. Nektar Therapeutics Recent Developments
- Table 36. ImmunityBio, Inc Basic Information List
- Table 37. ImmunityBio, Inc Description and Business Overview
- Table 38. ImmunityBio, Inc NK Cell Therapy Products, Services and Solutions
- Table 39. Revenue (US$ Million) in NK Cell Therapy Business of ImmunityBio, Inc (2020-2025)
- Table 40. ImmunityBio, Inc Recent Developments
- Table 41. GC Cell Basic Information List
- Table 42. GC Cell Description and Business Overview
- Table 43. GC Cell NK Cell Therapy Products, Services and Solutions
- Table 44. Revenue (US$ Million) in NK Cell Therapy Business of GC Cell (2020-2025)
- Table 45. GC Cell Recent Developments
- Table 46. Affimed Basic Information List
- Table 47. Affimed Description and Business Overview
- Table 48. Affimed NK Cell Therapy Products, Services and Solutions
- Table 49. Revenue (US$ Million) in NK Cell Therapy Business of Affimed (2020-2025)
- Table 50. Affimed Recent Developments
- Table 51. Innate Pharma SA Basic Information List
- Table 52. Innate Pharma SA Description and Business Overview
- Table 53. Innate Pharma SA NK Cell Therapy Products, Services and Solutions
- Table 54. Revenue (US$ Million) in NK Cell Therapy Business of Innate Pharma SA (2020-2025)
- Table 55. Innate Pharma SA Recent Developments
- Table 56. Fate Therapeutics Basic Information List
- Table 57. Fate Therapeutics Description and Business Overview
- Table 58. Fate Therapeutics NK Cell Therapy Products, Services and Solutions
- Table 59. Revenue (US$ Million) in NK Cell Therapy Business of Fate Therapeutics (2020-2025)
- Table 60. Fate Therapeutics Recent Developments
- Table 61. Glycostem Therapeutics Basic Information List
- Table 62. Glycostem Therapeutics Description and Business Overview
- Table 63. Glycostem Therapeutics NK Cell Therapy Products, Services and Solutions
- Table 64. Revenue (US$ Million) in NK Cell Therapy Business of Glycostem Therapeutics (2020-2025)
- Table 65. Glycostem Therapeutics Recent Developments
- Table 66. Dragonfly Therapeutics Basic Information List
- Table 67. Dragonfly Therapeutics Description and Business Overview
- Table 68. Dragonfly Therapeutics NK Cell Therapy Products, Services and Solutions
- Table 69. Revenue (US$ Million) in NK Cell Therapy Business of Dragonfly Therapeutics (2020-2025)
- Table 70. Dragonfly Therapeutics Recent Developments
- Table 71. Nkarta Therapeutics Basic Information List
- Table 72. Nkarta Therapeutics Description and Business Overview
- Table 73. Nkarta Therapeutics NK Cell Therapy Products, Services and Solutions
- Table 74. Revenue (US$ Million) in NK Cell Therapy Business of Nkarta Therapeutics (2020-2025)
- Table 75. Nkarta Therapeutics Recent Developments
- Table 76. Fortress Biotech Basic Information List
- Table 77. Fortress Biotech Description and Business Overview
- Table 78. Fortress Biotech NK Cell Therapy Products, Services and Solutions
- Table 79. Revenue (US$ Million) in NK Cell Therapy Business of Fortress Biotech (2020-2025)
- Table 80. Fortress Biotech Recent Developments
- Table 81. Nkure Basic Information List
- Table 82. Nkure Description and Business Overview
- Table 83. Nkure NK Cell Therapy Products, Services and Solutions
- Table 84. Revenue (US$ Million) in NK Cell Therapy Business of Nkure (2020-2025)
- Table 85. Nkure Recent Developments
- Table 86. Key Raw Materials Lists
- Table 87. Raw Materials Key Suppliers Lists
- Table 88. NK Cell Therapy Downstream Customers
- Table 89. NK Cell Therapy Distributors List
- Table 90. Research Programs/Design for This Report
- Table 91. Key Data Information from Secondary Sources
- Table 92. Key Data Information from Primary Sources
List of Figures
- Figure 1. NK Cell Therapy Product Picture
- Figure 2. Global NK Cell Therapy Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
- Figure 3. Global NK Cell Therapy Sales Value (2020-2031) & (US$ Million)
- Figure 4. NK Cell Therapy Report Years Considered
- Figure 5. Global NK Cell Therapy Players Revenue Ranking (2024) & (US$ Million)
- Figure 6. The 5 and 10 Largest Companies in the World: Market Share by NK Cell Therapy Revenue in 2024
- Figure 7. NK Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
- Figure 8. NK Cell Therapy Picture
- Figure 9. CAR-NK Cell Therapy Picture
- Figure 10. Global NK Cell Therapy Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
- Figure 11. Global NK Cell Therapy Sales Value Market Share by Type, 2024 & 2031
- Figure 12. Product Picture of Cancer
- Figure 13. Product Picture of Infectious Diseases
- Figure 14. Product Picture of Gastrointestinal Diseases
- Figure 15. Product Picture of Beauty and Anti-Aging
- Figure 16. Product Picture of Others
- Figure 17. Global NK Cell Therapy Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
- Figure 18. Global NK Cell Therapy Sales Value Market Share by Application, 2024 & 2031
- Figure 19. North America NK Cell Therapy Sales Value (2020-2031) & (US$ Million)
- Figure 20. North America NK Cell Therapy Sales Value by Country (%), 2024 VS 2031
- Figure 21. Europe NK Cell Therapy Sales Value, (2020-2031) & (US$ Million)
- Figure 22. Europe NK Cell Therapy Sales Value by Country (%), 2024 VS 2031
- Figure 23. Asia Pacific NK Cell Therapy Sales Value, (2020-2031) & (US$ Million)
- Figure 24. Asia Pacific NK Cell Therapy Sales Value by Region (%), 2024 VS 2031
- Figure 25. South America NK Cell Therapy Sales Value, (2020-2031) & (US$ Million)
- Figure 26. South America NK Cell Therapy Sales Value by Country (%), 2024 VS 2031
- Figure 27. Middle East & Africa NK Cell Therapy Sales Value, (2020-2031) & (US$ Million)
- Figure 28. Middle East & Africa NK Cell Therapy Sales Value by Country (%), 2024 VS 2031
- Figure 29. Key Countries/Regions NK Cell Therapy Sales Value (%), (2020-2031)
- Figure 30. United States NK Cell Therapy Sales Value, (2020-2031) & (US$ Million)
- Figure 31. United States NK Cell Therapy Sales Value by Type (%), 2024 VS 2031
- Figure 32. United States NK Cell Therapy Sales Value by Application (%), 2024 VS 2031
- Figure 33. Europe NK Cell Therapy Sales Value, (2020-2031) & (US$ Million)
- Figure 34. Europe NK Cell Therapy Sales Value by Type (%), 2024 VS 2031
- Figure 35. Europe NK Cell Therapy Sales Value by Application (%), 2024 VS 2031
- Figure 36. China NK Cell Therapy Sales Value, (2020-2031) & (US$ Million)
- Figure 37. China NK Cell Therapy Sales Value by Type (%), 2024 VS 2031
- Figure 38. China NK Cell Therapy Sales Value by Application (%), 2024 VS 2031
- Figure 39. Japan NK Cell Therapy Sales Value, (2020-2031) & (US$ Million)
- Figure 40. Japan NK Cell Therapy Sales Value by Type (%), 2024 VS 2031
- Figure 41. Japan NK Cell Therapy Sales Value by Application (%), 2024 VS 2031
- Figure 42. South Korea NK Cell Therapy Sales Value, (2020-2031) & (US$ Million)
- Figure 43. South Korea NK Cell Therapy Sales Value by Type (%), 2024 VS 2031
- Figure 44. South Korea NK Cell Therapy Sales Value by Application (%), 2024 VS 2031
- Figure 45. Southeast Asia NK Cell Therapy Sales Value, (2020-2031) & (US$ Million)
- Figure 46. Southeast Asia NK Cell Therapy Sales Value by Type (%), 2024 VS 2031
- Figure 47. Southeast Asia NK Cell Therapy Sales Value by Application (%), 2024 VS 2031
- Figure 48. India NK Cell Therapy Sales Value, (2020-2031) & (US$ Million)
- Figure 49. India NK Cell Therapy Sales Value by Type (%), 2024 VS 2031
- Figure 50. India NK Cell Therapy Sales Value by Application (%), 2024 VS 2031
- Figure 51. NK Cell Therapy Industrial Chain
- Figure 52. NK Cell Therapy Manufacturing Cost Structure
- Figure 53. Channels of Distribution (Direct Sales, and Distribution)
- Figure 54. Bottom-up and Top-down Approaches for This Report
- Figure 55. Data Triangulation
- Figure 56. Key Executives Interviewed
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.